Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B

David van Duin1, Arturo Casadevall, Joshua D Nosanchuk

  • 1Department of Medicine, Division of Infectious Diseases. Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Insights

Fungal melanin protects against certain antifungal drugs, but standard tests miss this effect. This finding explains treatment failures and highlights melanin's protective role against amphotericin B and caspofungin.

Area of Science:

  • Medical Mycology
  • Antimicrobial Resistance
  • Fungal Pathogenesis

Background:

  • Cryptococcus neoformans and Histoplasma capsulatum produce melanin.
  • Melanin production occurs in vitro and during infection.
  • The impact of fungal melanin on antifungal drug susceptibility is not fully understood.

Purpose of the Study:

  • To investigate if fungal melanization affects susceptibility to key antifungal drugs.
  • To determine the mechanism by which melanin might alter drug efficacy.
  • To correlate in vitro findings with potential in vivo clinical observations.

Main Methods:

  • Standardized broth macrodilution assays (MIC testing).
  • Fungal killing assays with melanized and non-melanized yeasts.
  • Incubation of antifungal drugs with purified fungal melanins.
  • Elemental analysis (C:N ratios) of drug-melanin interactions.

Main Results:

  • Melanization did not alter minimum inhibitory concentrations (MICs) for any tested drug.
  • Killing assays showed melanization reduced susceptibility to amphotericin B and caspofungin.
  • Melanins bound to amphotericin B and caspofungin, altering their chemical composition.
  • Fluconazole, itraconazole, and flucytosine efficacy was unaffected by melanin.

Conclusions:

  • Fungal melanin confers resistance to amphotericin B and caspofungin.
  • Standard MIC assays do not detect melanin-mediated drug resistance.
  • Melanin binding explains reduced efficacy of certain antifungals against Cryptococcus and Histoplasma.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...